L-Leucyl-L-prolyl-L-prolyl-L-seryl-L-arginine

DB17176ExperimentalProtein Based Therapies

L-Leucyl-L-prolyl-L-prolyl-L-seryl-L-arginine: Overview.

Also known as
H-Leu-Pro-Pro-Ser-Arg-OH · L-arginine, l-leucyl-l-prolyl-l-prolyl-l-seryl- · Lymphocyte Activating Pentapeptide

Resolves to

Compound
UNIIHFL33E395ICAS120484-65-3

Which companies are running trials of L-Leucyl-L-prolyl-L-prolyl-L-seryl-L-arginine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In